Literature DB >> 21058027

Expression and clinical significance of FAK and Src proteins in human endometrial adenocarcinoma.

Nikolaos A Chatzizacharias1, Constantinos Giaginis, Elisavet Gatzidou, Gerasimos Tsourouflis, Ioannis Sfiniadakis, Paraskevi Alexandrou, Stamatios E Theocharis.   

Abstract

Focal Adhesion Kinase (FAK) is a protein tyrosine kinase, localised in the focal adhesions, which, upon activation interacts with Src, another tyrosine kinase, regulating several cellular signalling pathways. Both enzymes have been implicated in malignant transformation and disease progression. The aim of the present study was to evaluate the clinical significance of FAK and Src expression in cases of endometrial adenocarcinoma. The total (t) and the activated, phosphorylated (p) forms of FAK and Src proteins were assessed immunohistochemically in tumour specimens obtained from 43 endometrial adenocarcinoma patients and were statistically analyzed in relation to various clinicopathological parameters and tumour proliferative capacity, reflected by Ki-67 labelling index. t-FAK positivity was significantly correlated with FIGO disease stage (p = 0.031), and t-FAK overexpression with patients' age (p = 0.015). No statistically significant correlation was identified between t-FAK staining intensity, t-Src positivity, overexpression or staining intensity and any of the clinicopathological parameters tested. No significant correlation was found between neither the positivity nor the intensity of staining of either p-FAk or p-Src with any of the parameters under study. Nonetheless, important, but non-significant, trends were identified between t-FAK staining intensity, t-Src positivity and overexpression and patients' survival (log rank, p = 0.122, p = 0.090 and p = 0.057 respectively). Similarly, p-FAK and p-Src staining characteristics seemed to correlate, even though non-significantly, with patients' survival (log rank, p = 0.051 and p = 0.070 for p-FAK and p-Src expression, respectively; log rank, p = 0.134 and p = 0.110 for p-FAK and p-Src staining intensity, respectively). These results support an important potential role of FAK-Src signalling in endometrial malignant disease progress and render further research in this field a necessity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21058027     DOI: 10.1007/s12253-010-9310-6

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  34 in total

Review 1.  Signaling through focal adhesion kinase.

Authors:  D D Schlaepfer; C R Hauck; D J Sieg
Journal:  Prog Biophys Mol Biol       Date:  1999       Impact factor: 3.667

2.  Evaluation of the clinical significance of focal adhesion kinase and SRC expression in human pancreatic ductal adenocarcinoma.

Authors:  Nikolaos A Chatzizacharias; Constantinos Giaginis; Diamanto Zizi-Serbetzoglou; Gregory P Kouraklis; Gabriel Karatzas; Stamatios E Theocharis
Journal:  Pancreas       Date:  2010-08       Impact factor: 3.327

Review 3.  Focal adhesion kinase.

Authors:  I Zachary
Journal:  Int J Biochem Cell Biol       Date:  1997-07       Impact factor: 5.085

4.  Mesodermal defect in late phase of gastrulation by a targeted mutation of focal adhesion kinase, FAK.

Authors:  Y Furuta; D Ilić; S Kanazawa; N Takeda; T Yamamoto; S Aizawa
Journal:  Oncogene       Date:  1995-11-16       Impact factor: 9.867

5.  Focal adhesion kinase overexpression in endometrial neoplasia.

Authors:  Chad A Livasy; Dominic Moore; William G Cance; Ruth A Lininger
Journal:  Appl Immunohistochem Mol Morphol       Date:  2004-12

Review 6.  Src in cancer: deregulation and consequences for cell behaviour.

Authors:  Margaret C Frame
Journal:  Biochim Biophys Acta       Date:  2002-06-21

Review 7.  Clinical significance of FAK expression in human neoplasia.

Authors:  Nikolaos A Chatzizacharias; Gregory P Kouraklis; Stamatios E Theocharis
Journal:  Histol Histopathol       Date:  2008-05       Impact factor: 2.303

8.  Bombesin, vasopressin, and endothelin stimulation of tyrosine phosphorylation in Swiss 3T3 cells. Identification of a novel tyrosine kinase as a major substrate.

Authors:  I Zachary; J Sinnett-Smith; E Rozengurt
Journal:  J Biol Chem       Date:  1992-09-25       Impact factor: 5.157

9.  Increase in activity and level of pp60c-src in progressive stages of human colorectal cancer.

Authors:  M S Talamonti; M S Roh; S A Curley; G E Gallick
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

10.  Conditional knockout of focal adhesion kinase in endothelial cells reveals its role in angiogenesis and vascular development in late embryogenesis.

Authors:  Tang-Long Shen; Ann Y-J Park; Ana Alcaraz; Xu Peng; Ihnkyung Jang; Pandelakis Koni; Richard A Flavell; Hua Gu; Jun-Lin Guan
Journal:  J Cell Biol       Date:  2005-06-20       Impact factor: 10.539

View more
  1 in total

1.  FAK and Src expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival.

Authors:  Stamatios Theocharis; Jerzy Klijanienko; Constantinos Giaginis; Paraskevi Alexandrou; Efstratios Patsouris; Xavier Sastre-Garau
Journal:  J Cancer Res Clin Oncol       Date:  2012-04-10       Impact factor: 4.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.